PriceSensitive

MedAdvisor (ASX:MDR) fast-tracks delivery service for pharmacies

Health Care
ASX:MDR      MCAP $170.5M
26 March 2020 14:40 (AEST)

MedAdvisor (MDR) has fast-tracked the rollout of Phase 1 of its delivery service to help pharmacies and patients during the COVID-19 pandemic.

By fast-tracking the launch, MedAdvisor is helping relieve the pressure on pharmacies who are struggling to keep up with demand.

This home delivery service enable patients to order, pay for, and request delivery of their medications from the MedAdvisor App.

As part of the COVID-19 package, the Australian Federal Government has guaranteed $25 million to deliver much-needed medication to those at risk and unable to leave their homes.

Temporary measures have been put in place to provide non-contact delivery to avoid unnecessary contact with vulnerable patients.

Sourced: MedAdvisor

However, MedAdvisor is not changing the way medication is distributed as many pharmacies already offer some form of delivery to their customers.

MedAdvisor will allow pharmacies to use their own service, usually pharmacy staff, or MedAdvisor’s own delivery partner.

Announced on November 1, Phase 2 of the delivery service will allow pharmacies to offer same-day delivery by using MedAdvisor’s deliver provider, Kings Transport.

Rollout of Phase 2 is planned to begin in the second half of the 2020 financial year and will first focus on major metropolitan centres.

“MedAdvisor is playing a critical role in remote medicines management in Australia during this health crisis,” CEO Robert Read said.

“Our tools allow patients to track, manage and order their medications whilst at home. Now with the ability to pay in advance and request delivery from your pharmacy, it can streamline the workflow for community pharmacies when managing patients remotely,” he added.

MedAdvisor is up a steady 24.2 per cent on the market and shares are trading for 41 cents each at 2:23 pm AEDT.

Related News